Hepatitis C

Home
Keys to Success in Medicine
Cardiovascular System
Respiratory System
Locomotor System
Endocrine and Metabolic System
Kidneys and Urinary System
Gastrointestinal Tract
Central Nervous System
Haematological System
Integumental System
Reproductive and Genital System
Recommended Reading
Forum
Links

amazon astore

ydr

aces for paces

Clinical Skills Blogspot

 

Google
Web ydr.org.uk
acesforpaces.com medicalrevision.org

 

 

Chronic Hepatitis C infection

Title               

Ñ    Chronic Hepatitis C infection

Definition

Ñ    Chronic infection

With the:

Ñ    Hepatitis C virus

Aetiology

Ñ    RNA virus (Flavivirus)

Ñ    6 Genotypes

Pathogenesis

Transmission

Ñ    Blood and blood products

Ñ    Intravenous drug abuse

Ñ    Limited role of sexual transmission in long-term heterosexual relationships

Ñ    Increased risk in homosexuals

Ñ    Vertical transmission from mother to child uncommon

Ñ    20% mode of transmission unknown

Aggravating factors

The course of the illness is adversely affected by:

Ñ    Alcohol consumption

Ñ    Male sex

Ñ    Acquiring infection after the age of 40 years

Ñ    Genotype 1 or 4

Pathological Process

Ñ    Chronic hepatitis in > 50 % of those infected

Ñ    Half progress to cirrhosis

Clinical Features

Ñ    Most acute infections are asymptomatic

Ñ    10 % of patients have a flu like illness with jaundice and elevated serum aminotransferases

E&M

Ñ    Higher incidence of diabetes mellitus

Ñ    Fatigue

IS

Ñ    Porphyria cutanea tarda

GIT

Ñ    Abnormal serum aminotransferases

Ñ    Chronic liver disease

KUS

Ñ    Glomerulonephritis associated with cryoglobulinaemia

LMS

Ñ    Arthritis

Ñ    Sjögren’s syndrome

Complications

GIT

Ñ    Cirrhosis of the liver

Ñ    Hepatocellular carcinoma

Investigations

Fluids

Blood

Microbiology

Ñ    HCV RNA:

May be detected 1 or 2 weeks after infection

Ñ    Anti-HCV antibody:

Usually positive 6 weeks after infection

Management

Cure

Drugs

Ñ     Ribavarin

Biological Agents

Ñ    Pegylated interferon

Support

Biological Agents

Ñ    Liver transplantation for end stage cirrhosis

Prognosis

Ñ    Genotype 1 is the most difficult to treat

Back ] Up ] Next ]

 

 

[Up]